Checking long-term beta-blocker use after a heart attack
Part of Heart & circulation clinical trials.
This study looks at people who have already been on a beta-blocker for at least a year after a heart attack. It aims to understand how long-term beta-blocker treatment affects heart health and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 19 years old
- Have stayed on a beta-blocker for at least 1 year after your heart attack
- Be able to understand the study and agree in writing (you or a legal representative)
- Have heart ultrasound (echocardiogram) after the heart attack showing an ejection fraction of 40% or higher
- Have no history of heart failure and no conditions that prevent beta-blocker use
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether people who have stayed in normal rhythm one year after atrial fibrillation ablation should continue blood thinning treatment. It may help guide safer, more personalized choices about long-term blood thinners after a successful procedure.
This trial tests whether people whose heart function has returned to normal after heart failure can safely stop taking beta-blockers. It aims to see if staying on the medication is still needed or if stopping is just as safe.
This trial tests a heart medication (a cardio-selective beta-blocker) given during a heart attack to see if it reduces damage to the heart muscle. It might help people having their first heart attack who are treated quickly with angioplasty (a procedure to open blocked arteries).
This trial tests whether it is safe to gradually stop beta-blocker medication in older adults with heart failure with preserved ejection fraction (a type of heart failure where the heart pumps normally but is stiff). It aims to improve quality of life by reducing unnecessary medications.
This study checks whether safely stopping beta-blocker medicine is possible in some people with heart failure with preserved pumping (EF ≥50%). It may help by testing whether reducing the medication is safe and workable for certain patients.
This trial is a long-term check-in for people who survived a heart attack and already took part in an earlier study through a 1-year follow-up. The goal is to learn what happens over time after the heart attack and how participants are doing.
Hear when a new Myocardial Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.